Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Touchlight Genetics

Biotech & Life Sciences · London, United Kingdom · Founded 2007 Unicorn

Develops a DNA production platform designed for the development of DNA vaccines for oncology and infectious diseases

Valuation
$1–2.5B
Latest valuation · 2026
Unlock exact value
Revenue
$10–50M
Latest reported FY
Unlock exact value
Headcount
100–500
Current team size
Unlock exact value

Investors

4 investors on Touchlight Genetics's cap table

Sourced from Dealroom's funding history.

Series A 1 investor entered at this stage
Downing Ventures
Series B+ 3 investors entered at this stage
Novator
Bridford Group
Bridford Investments

Ownership

Who owns Touchlight Genetics

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.

22% Founders

Some investors are hidden on this public profile. See the full cap table on Dealroom →

Global footprint

Where Touchlight Genetics has talent and traffic

Workforce by country
8 countries with
team presence
🇬🇧 United Kingdom91.9%
🇺🇸 United States4.5%
🇮🇪 Ireland0.7%
🇦🇪 United Arab Emirates0.7%
🇫🇷 France0.7%
Top 5 of 8 shown
Web traffic by country
10K monthly visits
across markets
🇬🇧 United Kingdom70%
🇺🇸 United States27%
🇮🇳 India7%
🇪🇸 Spain1%
Top 4 markets shown

Talent graph

The shape of Touchlight Genetics's talent

Dealroom maps Touchlight Genetics's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

24 standout operatorsDealroom-flagged across the org
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Touchlight Genetics's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$22M patent portfolio · 13 active families

Estimated portfolio value
$22M
2.2% of valuation · 122.3× smaller than top peer Illumina ($2.7B)
13 active patent families
Where Touchlight Genetics innovates Cell freePolymeraseA-DNADNA synthesisDna template

Where Touchlight Genetics concentrates vs peers

Each axis is a top-10 topic across Touchlight Genetics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Touchlight Genetics

An AI-synthesized read of the highest-engagement posts about Touchlight Genetics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Touchlight Genetics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.